Our data support the finding that Apelin-13 regulates antioxidant signaling to ameliorate inflammation-induced AD symptoms, and it remains to be thoroughly investigated whether others, such as inflammatory factors, neurotransmitter signaling, etc., are also involved and whether this pathway still plays a role in Apelin-13’s treatment of other causes of AD. Here, APLN is linked to Alzheimer disease.